In both cohorts , we identified a hyperinflammatory subphenotype ( phenotype 2 ) that was characterised by higher plasma concentrations of inflammatory biomarkers , a higher prevalence of vasopressor use , lower serum bicarbonate concentrations , and a higher prevalence of sepsis than phenotype 1 .